Skip to main content
Clinical Trials/NCT04230343
NCT04230343CompletedNot Applicable

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza

SB Istanbul Education and Research Hospital2 sites in 1 country244 target enrollmentStarted: November 13, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
244
Locations
2
Primary Endpoint
Vaccine uptake following the introduction of the pamphlet

Study Overview

Brief Summary

Influenza vaccine uptake remains low worldwide, inflicting substantial costs to public health and health systems. Messages promoting social welfare have been shown to increase vaccination intentions, and it has been recommended that health professionals communicate the socially beneficial aspects of vaccination. This study aims to provide the first test whether this prosocial vaccination hypothesis applies to the actual vaccination behaviour of high-risk patients by comparing the effects of two motivational messages for promoting vaccination at a tertiary care public hospital in Istanbul, Turkey.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients hospitalized at medical departments of the hospital who are on the day of discharge

Exclusion Criteria

  • Egg ellergy
  • Previous allergic reaction to influenza vaccine
  • Pregnancy
  • Cognitive disability

Outcomes

Primary Outcomes

Vaccine uptake following the introduction of the pamphlet

Time Frame: On the same day, upto 24 hours

Difference in the number of patients in each arm who agree to receive influenza vaccine following the introduction of the pamphlet. The first half of the pamphlet contains information about the the influenza vaccine and the risk groups who are vulnerable to influenza-associated serious diseases. The second half introduces the self-benefit message. And the final part asks if the participant wants to receive the influenza vaccine now.

Secondary Outcomes

  • Vaccine uptake in high and low risk group patients following the introduction of the pamphlet(On the same day, upto 24 hours)

Investigators

Sponsor
SB Istanbul Education and Research Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Burcu Isler

Principal investigator

SB Istanbul Education and Research Hospital

Study Sites (2)

Loading locations...

Similar Trials